MAX BioPharma

MAX BioPharma is a biotech start-up leveraging small molecule lipids to create the next generation of treatments for fatal and debilitating disorders.

[MAX BioPharma @maxbiopharma]

MAX BioPharma announces key update on its anti-fibrotic and anti-inflammatory oxysterol drug candidate that inhibits MASH, atherosclerosis, and fat tissue inflammation. #oxysteroltherapeutics #mash #atherosclerosis #inflammation #fibrosis

https://t.co/QYEs8U93S4

[MAX BioPharma @maxbiopharma]

We are seeking scientific collaborations and private investment support to examine Oxy210 in vivo in preclinical models of CKD that would pave the way for its future evaluation in humans. #kidney #chronickidneydisease #fibrosis #oxysterol #Oxy210 #OxysterolTherapeutics

[MAX BioPharma @maxbiopharma]

Fibrosis is a hallmark of CKD. In a recent publication we reported the in vitro anti-fibrotic effects of Oxy210 on human kidney cells involved in fibrosis and CKD, namely renal fibroblasts, pericytes, mesangial cells, and renal tubular epithelial cells.

https://t.co/cDFp6OT9jf

[MAX BioPharma @maxbiopharma]

Metaba and MAX BioPharma Announce Breakthrough Progress on Next-Generation Oxysterol-Based Antibiotics #metaba #maxbiopharma #oxysteroltherapeutics #oxysterol #antibiotic #tuberculosis #drugresistance

https://t.co/lKWSKxVfgN

[MAX BioPharma @maxbiopharma]

We are proud to announce the publication of our paper that demonstrates for the first time, in a humanized mouse model, that an oxysterol-based drug candidate, Oxy210, with anti-inflammatory and anti-fibrotic properties, ameliorates atherosclerosis.
https://t.co/4yCQi0Up9V

[MAX BioPharma @maxbiopharma]

We thank the @SoCalBio team for having us at this year’s SoCalBio 26th Annual Investor Conference where MAX BioPharma shared key updates for OxyFuse-133 for spinal fusion and Oxy210 for treating MASH. The company is seeking investors to initiate Phase 1 studies in 2025. #LongLA

[MAX BioPharma @maxbiopharma]

UCLA Alumni Association presents this year's 2024 Bruin Business 100! Our founder, Farhad Parhami, is proud to be recognized as part of the Bruin Business 2024 honorees. Check out the full list of celebrated businesses here: https://t.co/S15dJgEvSJ #BruinBusinesses @UCLA_Alumni

[MAX BioPharma @maxbiopharma]

MAX BioPharma's Oxysterol Therapeutics Platform technology continues to provide insights into the potential of our drug candidates in additional disease areas, most recently in cystic fibrosis (CF). #Oxysterol #Cysticfibrosis #Inflammation #CFF #Metaba #MaxBioPharma

[MAX BioPharma @maxbiopharma]

Congratulations to the @biocom team for yet another successful and well-organized Global Partnering & Investor Conference! A huge learning experience and a superb opportunity to form new collaborations and partnerships. #BGIP #Biocom #Metaba #MAXBioPharma

[MAX BioPharma @maxbiopharma]

The Global Life Science Partnering and Investor Conference 2024 is here. MAX BioPharma will be presenting on Wednesday. Don't miss it! #biocomCA #biocomglobalpartnering2024 #maxbiopharma #oxysteroltherapeutics

[MAX BioPharma @maxbiopharma]

MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies! Learn more:

https://t.co/pcI2E6KzSd

[MAX BioPharma @maxbiopharma]

MAX BioPharma will be attending the 2024 Biocom Global Life Science Partnering & Investor Conference in San Diego from Feb 27th-29th to present on #OxysterolTherapeutics. #maxbiopharma #Metaba #Oxysterol #NASH #IPF #BoneRegeneration #Cancer #Cysticfibrosis
https://t.co/PF5m6TivE4

[MAX BioPharma @maxbiopharma]

MAX BioPharma attended the Team Launch Event by Nucleate LA Activator Program 2023-2024! Many thanks to the organizers, panelists and attendees that make Nucleate a truly invaluable opportunity for young entrepreneurs starting companies. #LA #biotech

[MAX BioPharma @maxbiopharma]

Thanks Dave Whelan and @BioscienceLA for a great Beach Day networking event!
#BioscienceLA

[MAX BioPharma @maxbiopharma]

MAX BioPharma's latest publication in collaboration with the National Institute of Infectious Diseases, Japan: "Selective inhibition of hepatitis B virus internalization by oxysterol derivatives"
https://t.co/ktclTThHql
#hbv #oxysterols #oxysteroltherapeutics

[MAX BioPharma @maxbiopharma]

A quick overview of today's biotech venture capital market and outlook. Learn more:

https://t.co/DC8O6NLZvN

#biotech #venturecapital #oxysteroltherapeutics #fundraising

[MAX BioPharma @maxbiopharma]

The MAX BioPharma team is super excited that our new and improved website is now live. Please check it out. https://t.co/9E7ZNVNeJs

#maxbiopharma #oxysterols #oxysteroltherapeutics

[MAX BioPharma @maxbiopharma]

MAX BioPharma was proud to participate in the Biocom Global Partnering Conference last week in San Diego. Our CEO, Farhad Parhami, presented on the company during a presentation session. #BiocomGPIC #MAXBioPharma #oxysterols #oxysteroltherapeutics

[MAX BioPharma @maxbiopharma]

We would like to thank @biocom for the opportunity to present at this week's Global Life Science Partnering & Investor Conference! #BiocomGPIC #lifescience #globalpartnering #oxysteroltherapeutics #oxysterols

[MAX BioPharma @maxbiopharma]

Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval https://t.co/xoHYgzzNe8

#nash #oxysterol #oxysteroltherapeutics #oxy210 #fibrosis #liver